MusthInsider

Latest On Fulcrum Therapeutics, Inc (FULC):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-24 17:06 EST	News	Fulcrum Therapeutics: FSHD Steadily Advancing In Phase 3, Optionality With SCD	N/A
2023-05-16 00:01 EST	News	Fulcrum Therapeutics, Inc. (FULC) Q1 2023 Earnings Call Transcript	N/A
2023-05-15 10:14 EST	News	Fulcrum Therapeutics GAAP EPS of -$0.41 beats by $0.05, revenue of $0.3M misses by $0.68M	N/A
2023-05-15 10:14 EST	News	Fulcrum Therapeutics appoints new executive chief	N/A
2023-05-05 01:13 EST	News	Fulcrum slips as Goldman Sachs downgrades on limited catalyst path	N/A
2023-04-25 17:38 EST	News	Fulcrum Therapeutics: Barrage Of Bad News In 2023 But Key Catalysts Remain	N/A
2023-04-05 22:41 EST	News	Fulcrum Therapeutics CFO resigns	N/A
2023-03-10 23:32 EST	News	Fulcrum Therapeutics downgraded to neutral at Credit Suisse on sickle cell candidate	N/A
2023-03-10 23:31 EST	News	Fulcrum Therapeutics, Inc. (FULC) Q4 2022 Earnings Call Transcript	N/A
2023-03-09 16:52 EST	News	Fulcrum Therapeutics GAAP EPS of -$0.50 misses by $0.01, revenue of $0.7M misses by $1.19M	N/A
2023-03-09 16:52 EST	News	Fulcrum plunges 23% after Q4 update as medical chief departs	N/A
2023-02-24 17:52 EST	News	Fulcrum Therapeutics plunges 55% on clinical hold for sickle cell treatments	N/A
2023-02-13 20:23 EST	News	Fulcrum's Losmapimod: A Potential Aid, But Its Ability To Modify The Disease Remains Uncertain	N/A
2023-01-18 07:27 EST	News	Fulcrum Therapeutics shares slide after pricing $125M upsized stock offering	N/A
2023-01-17 20:15 EST	News	Fulcrum Therapeutics commences $100M underwritten public offering of shares	N/A
2023-01-04 19:34 EST	News	Fulcrum Therapeutics names new CEO and provides business outlook	N/A
2022-11-12 22:51 EST	News	Fulcrum Therapeutics, Inc. (FULC) Q3 2022 Earnings Call Transcript	N/A
2022-11-08 12:30 EST	News	Fulcrum Therapeutics GAAP EPS of -$0.51 beats by $0.11, revenue of $1.18M misses by $1.36M	N/A
2022-11-07 19:00 EST	News	Fulcrum Therapeutics names new chief medical officer, chief scientific officer	N/A
2022-08-16 08:01 EST	News	Fulcrum Therapeutics stock dips on offering of $75M shares	N/A
2022-08-16 08:01 EST	News	Fulcrum prices ~$75M stock offering	N/A
2022-08-12 02:43 EST	News	Fulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q2 2022 Results - Earnings Call Transcript	N/A
2022-08-11 09:44 EST	News	Fulcrum Therapeutics GAAP EPS of -$0.83 misses by $0.17, revenue of $1.9M misses by $1.06M	N/A
2022-07-11 19:26 EST	News	Fulcrum Therapeutics says chief medical officer Christopher Morabito to leave	N/A
2022-07-06 05:55 EST	News	Fulcrum begins dosing in late-stage study of losmapimod for rare muscle disorder	N/A
2022-06-28 04:00 EST	News	Fulcrum Therapeutics: Value Loss On SCD Data Update Is Telling	N/A
2022-06-10 23:46 EST	News	Fulcrum crashes 48% after announcing early-stage data sickle cell disease candidate	N/A
2022-06-08 03:53 EST	News	Fulcrum gains as Merck ends deal for lung disease candidates	N/A
2022-05-10 06:03 EST	News	Fulcrum Therapeutics' (FULC) CEO Bryan Stuart on Q1 2022 Results - Earnings Call Transcript	N/A
2022-05-09 10:26 EST	News	Fulcrum Therapeutics GAAP EPS of -$0.64 misses by $0.02, revenue of $2.6M misses by $1.34M	N/A
2022-03-08 13:53 EST	News	Fulcrum rises as Oppenheimer highlights sickle cell disease candidate	N/A
2022-03-03 11:48 EST	News	Fulcrum Therapeutics GAAP EPS of -$0.58 beats by $0.09, revenue of $5.06M beats by $1.54M	N/A
2022-03-03 11:48 EST	News	Fulcrum plans phase 3 trial of losmapimod to treat rare muscle disorder	N/A
2022-03-03 11:48 EST	News	Fulcrum Therapeutics, Inc.'s (FULC) CEO Bryan Stuart On Q4 2021 Results - Earnings Call Transcript	N/A
2022-02-11 21:58 EST	News	Fulcrum Therapeutics grants inducement options to one new employee	N/A
2022-01-08 15:26 EST	News	Biogen, Galapagos and Ultragenyx among key biotech calls at Morgan Stanley for 2022	N/A
2022-01-04 13:05 EST	News	Fulcrum Therapeutics hires CFO	N/A
2021-11-06 20:44 EST	News	Fulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q3 2021 results - Earnings Call Transcript	N/A
2021-09-03 15:55 EST	News	Fulcrum Therapeutics: Multiple Interesting Programs, Needs A Better Entry Point	N/A
2021-08-12 17:25 EST	News	Fulcrum Therapeutics raises $125M via equity offering	N/A
2021-08-11 21:00 EST	News	Bluebird bio price target cut; Fulcrum upgraded as Morgan Stanley shakes up SCD coverage	N/A
2021-08-11 01:17 EST	News	Fulcrum Therapeutics surges on early-stage results for sickle cell disease therapy	N/A
2021-08-11 01:16 EST	News	Fulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q2 2021 Results - Earnings Call Transcript	N/A
2021-08-11 01:15 EST	News	Fulcrum Therapeutics more than doubles as Stifel raises price target	N/A
2021-08-11 01:15 EST	News	Fulcrum Therapeutics shares under pressure after $100M capital raise	N/A
2021-07-21 09:26 EST	News	Fulcrum Therapeutics reports results mid-stage losmapimod study in rare disabling disease	N/A
2021-07-21 09:26 EST	News	Stifel nearly doubles Fulcrum price target, assumes 354% upside	N/A
2021-07-21 09:24 EST	News	MRIN, ALT, FLXN and FULC among after-hours movers	N/A
2021-05-06 12:07 EST	News	Fulcrum Therapeutics beats on revenue	N/A
2021-05-06 12:06 EST	News	Fulcrum Therapeutics has a new medical chief	N/A

About Fulcrum Therapeutics, Inc (FULC):

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that is in Phase 2b clinical trial for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-6058, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and ß-thalassemia. The company is also discovering drug targets for the treatments of muscle, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

See Advanced Chart

General

Name Fulcrum Therapeutics, Inc
Symbol FULC
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 73
Fiscal Year EndDecember
IPO Date2019-07-18
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryPharmaceuticals
Web URLhttp://www.fulcrumtx.com

Valuation

Trailing PE 267
Price/Sales (Trailing 12 Mt.) 34.37
Price/Book (Most Recent Quarter) 4.11
Enterprise Value Revenue 31.49

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$2.87
Next Year EPS Estimate -$3.06
Next Quarter EPS Estimate -$0.66
Operating Margin -812%
Return on Assets -37%
Return on Equity -78%
Revenue 8.82 million
Earnings Per Share -$50.40
Revenue Per Share $0.35
Gross Profit -46839000
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 405.79 million
EBITDA -67074000
PE Ratio -26.37
Analyst Target Price $18
Book Value Per Share $4.53

Share Statistics

Shares Outstanding 32.67 million
Shares Float 18.96 million
% Held by Insiders 3552%
% Held by Institutions 76.11%
Shares Short 690946
Shares Short Prior Month 724097
Short Ratio 4.81
Short % of Float 3%
Short % of Shares Outstanding 2%

Technicals

52 Week High $22.39
52 Week Low $7.01
50 Day Moving Average 12.75
200 Day Moving Average 11.21

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Fulcrum Therapeutics, Inc (FULC) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Fulcrum Therapeutics, Inc (FULC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-04	$4.23 million	-$0.63	-$0.73	13.1%
2020-09-30	2020-11-10	$N/A	-$0.70	-$0.64	-9.8%
2020-06-30	2020-08-11	$N/A	-$0.66	-$0.75	11.61%
2020-03-31	2020-05-13	$750000	-$0.81	-$0.76	-6.58%
2019-12-31	2020-03-05	$N/A	-$0.71	-$0.88	19.62%
2019-09-30	2019-11-14	$N/A	-$0.97	-$0.72	-34.72%
2019-06-30	2019-08-26	$N/A	-$0.71	-$0.75	5.33%

Fulcrum Therapeutics, Inc (FULC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Fulcrum Therapeutics, Inc (FULC) Chart:

Fulcrum Therapeutics, Inc (FULC) News:

Below you will find a list of latest news for Fulcrum Therapeutics, Inc (FULC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Fulcrum Therapeutics, Inc (FULC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2026-04-17	3	0	CALL	0	0	248.44	TRUE	0	0
2026-04-17	4	0	CALL	0	0	0	TRUE	0	0
2026-04-17	5	2.21	CALL	0	1	115.14	TRUE	0	0
2026-04-17	6	0	CALL	0	0	58.22	TRUE	0	0
2026-04-17	7	0.71	CALL	0	625	102.5	FALSE	0	0
2026-04-17	8	0.31	CALL	0	128	112.44	FALSE	0	0
2026-04-17	9	0.17	CALL	0	5	148.06	FALSE	0	0
2026-04-17	10	0.15	CALL	0	266	234.3	FALSE	0	0
2026-04-17	11	0	CALL	0	0	260.03	FALSE	0	0
2026-04-17	12	0	CALL	0	0	282.26	FALSE	0	0
2026-04-17	13	0	CALL	0	0	301.82	FALSE	0	0
2026-04-17	14	0	CALL	0	0	319.29	FALSE	0	0
2026-04-17	15	1	CALL	0	40	335.05	FALSE	0	0
2026-04-17	16	0	CALL	0	0	349.4	FALSE	0	0
2026-04-17	17	0	CALL	0	0	395.85	FALSE	0	0
2026-04-17	18	0	CALL	0	0	374.73	FALSE	0	0
2026-04-17	19	0	CALL	0	0	386.02	FALSE	0	0
2026-04-17	20	0	CALL	0	0	396.55	FALSE	0	0
2026-04-17	3	0.05	PUT	0	20	210.37	FALSE	0	0
2026-04-17	4	0	PUT	0	0	420.81	FALSE	0	0
2026-04-17	5	0	PUT	0	0	269.34	FALSE	0	0
2026-04-17	6	0.21	PUT	0	303	111.18	FALSE	0	0
2026-04-17	7	0.94	PUT	0	7	103.13	TRUE	0	0
2026-04-17	8	1.65	PUT	0	37	105.33	TRUE	0	0
2026-04-17	9	1.25	PUT	0	100	90.07	TRUE	0	0
2026-04-17	10	0	PUT	0	0	127.3	TRUE	0	0
2026-04-17	11	0	PUT	0	0	115.45	TRUE	0	0
2026-04-17	12	0	PUT	0	0	131.94	TRUE	0	0
2026-04-17	13	0	PUT	0	0	146.72	TRUE	0	0
2026-04-17	14	0	PUT	0	0	160.12	TRUE	0	0
2026-04-17	15	0	PUT	0	0	172.39	TRUE	0	0
2026-04-17	16	0	PUT	0	0	183.71	TRUE	0	0
2026-04-17	17	0	PUT	0	0	194.22	TRUE	0	0
2026-04-17	18	0	PUT	0	0	228.88	TRUE	0	0
2026-04-17	19	0	PUT	0	0	213.25	TRUE	0	0
2026-04-17	20	0	PUT	0	0	221.91	TRUE	0	0
2026-05-15	1	0	CALL	0	0	216	TRUE	0	0
2026-05-15	2	0	CALL	0	0	176.32	TRUE	0	0
2026-05-15	3	0	CALL	0	0	0	TRUE	0	0
2026-05-15	4	0	CALL	0	0	156.12	TRUE	0	0
2026-05-15	5	0	CALL	0	0	0	TRUE	0	0
2026-05-15	6	0	CALL	0	0	119.08	TRUE	0	0
2026-05-15	7	0	CALL	0	0	121.54	FALSE	0	0
2026-05-15	8	0.65	CALL	3	3	99.28	FALSE	0.65	0
2026-05-15	9	0	CALL	0	0	116.54	FALSE	0	0
2026-05-15	10	0	CALL	0	0	165.12	FALSE	0	0
2026-05-15	11	0	CALL	0	0	171.98	FALSE	0	0
2026-05-15	12	0	CALL	0	0	186.75	FALSE	0	0
2026-05-15	13	0	CALL	0	0	199.74	FALSE	0	0
2026-05-15	14	0	CALL	0	0	211.34	FALSE	0	0
2026-05-15	1	0	PUT	0	0	310.4	FALSE	0	0
2026-05-15	2	0	PUT	0	0	478.34	FALSE	0	0
2026-05-15	3	0	PUT	0	0	391.87	FALSE	0	0
2026-05-15	4	0	PUT	0	0	280	FALSE	0	0
2026-05-15	5	0	PUT	0	0	133.21	FALSE	0	0
2026-05-15	6	0	PUT	0	0	135.47	FALSE	0	0
2026-05-15	7	0	PUT	0	0	123.81	TRUE	0	0
2026-05-15	8	0	PUT	0	0	126.44	TRUE	0	0
2026-05-15	9	0	PUT	0	0	132.39	TRUE	0	0
2026-05-15	10	0	PUT	0	0	78.61	TRUE	0	0
2026-05-15	11	0	PUT	0	0	130.44	TRUE	0	0
2026-05-15	12	0	PUT	0	0	130.7	TRUE	0	0
2026-05-15	13	0	PUT	0	0	134.82	TRUE	0	0
2026-05-15	14	0	PUT	0	0	125.82	TRUE	0	0
2026-06-18	1	0	CALL	0	0	146.19	TRUE	0	0
2026-06-18	2	0	CALL	0	0	177.62	TRUE	0	0
2026-06-18	3	0	CALL	0	0	137.08	TRUE	0	0
2026-06-18	4	0	CALL	0	0	130.82	TRUE	0	0
2026-06-18	5	6.5	CALL	0	3	135.85	TRUE	0	0
2026-06-18	6	1.86	CALL	0	1	130.48	TRUE	0	0
2026-06-18	7	4.2	CALL	0	7	162.11	FALSE	0	0
2026-06-18	8	1.25	CALL	0	3005	134.56	FALSE	0	0
2026-06-18	9	0.7	CALL	3	37	99.33	FALSE	-0.14	-0.17
2026-06-18	10	0.4	CALL	0	211	130.79	FALSE	0	0
2026-06-18	11	0.05	CALL	0	10	148.16	FALSE	0	0
2026-06-18	12	0.38	CALL	0	126	124.23	FALSE	0	0
2026-06-18	13	1.08	CALL	0	11	126.81	FALSE	0	0
2026-06-18	14	2.25	CALL	0	4	162.64	FALSE	0	0
2026-06-18	15	0.2	CALL	0	107	170.73	FALSE	0	0
2026-06-18	16	1.09	CALL	0	23	178.09	FALSE	0	0
2026-06-18	17	2.3	CALL	0	4	184.85	FALSE	0	0
2026-06-18	18	2.1	CALL	0	11	191.08	FALSE	0	0
2026-06-18	19	0	CALL	0	0	196.87	FALSE	0	0
2026-06-18	20	2.1	CALL	0	1	202.27	FALSE	0	0
2026-06-18	21	1.7	CALL	0	1	207.33	FALSE	0	0
2026-06-18	22	0	CALL	0	0	212.08	FALSE	0	0
2026-06-18	23	0	CALL	0	0	216.57	FALSE	0	0
2026-06-18	24	0	CALL	0	0	335.93	FALSE	0	0
2026-06-18	25	0	CALL	0	0	224.83	FALSE	0	0
2026-06-18	26	0	CALL	0	0	228.65	FALSE	0	0
2026-06-18	27	0	CALL	0	0	232.29	FALSE	0	0
2026-06-18	28	0	CALL	0	0	347.92	FALSE	0	0
2026-06-18	1	0	PUT	0	0	0	FALSE	0	0
2026-06-18	2	0	PUT	0	0	0	FALSE	0	0
2026-06-18	3	0	PUT	0	0	259.25	FALSE	0	0
2026-06-18	4	0	PUT	0	0	216.81	FALSE	0	0
2026-06-18	5	0	PUT	0	0	133.78	FALSE	0	0
2026-06-18	6	1	PUT	1	359	118.44	FALSE	-0.05	-0.05
2026-06-18	7	1.2	PUT	0	665	127.67	TRUE	0	0
2026-06-18	8	2.5	PUT	0	52	127.02	TRUE	0	0
2026-06-18	9	2.1	PUT	0	23	122.84	TRUE	0	0
2026-06-18	10	2.45	PUT	0	121	123.74	TRUE	0	0
2026-06-18	11	3.1	PUT	0	12	87.18	TRUE	0	0
2026-06-18	12	0	PUT	0	0	123.47	TRUE	0	0
2026-06-18	13	3.5	PUT	0	10	128.76	TRUE	0	0
2026-06-18	14	4.2	PUT	0	11	127.24	TRUE	0	0
2026-06-18	15	6.1	PUT	0	2	123.17	TRUE	0	0
2026-06-18	16	0	PUT	0	0	123.12	TRUE	0	0
2026-06-18	17	0	PUT	0	0	121.12	TRUE	0	0
2026-06-18	18	0	PUT	0	0	0	TRUE	0	0
2026-06-18	19	0	PUT	0	0	121.19	TRUE	0	0
2026-06-18	20	0	PUT	0	0	126.2	TRUE	0	0
2026-06-18	21	0	PUT	0	0	0	TRUE	0	0
2026-06-18	22	0	PUT	0	0	0	TRUE	0	0
2026-06-18	23	0	PUT	0	0	0	TRUE	0	0
2026-06-18	24	0	PUT	0	0	0	TRUE	0	0
2026-06-18	25	0	PUT	0	0	0	TRUE	0	0
2026-06-18	26	0	PUT	0	0	0	TRUE	0	0
2026-06-18	27	0	PUT	0	0	0	TRUE	0	0
2026-06-18	28	0	PUT	0	0	0	TRUE	0	0
2026-09-18	2	0	CALL	0	0	0	TRUE	0	0
2026-09-18	3	0	CALL	0	0	0	TRUE	0	0
2026-09-18	4	0	CALL	0	0	0	TRUE	0	0
2026-09-18	5	0	CALL	0	0	55.14	TRUE	0	0
2026-09-18	6	0	CALL	0	1	70.11	TRUE	0	0
2026-09-18	7	0	CALL	0	0	76.25	FALSE	0	0
2026-09-18	8	1.51	CALL	0	11	83.94	FALSE	0	0
2026-09-18	9	1.8	CALL	0	1	240.94	FALSE	0	0
2026-09-18	10	1.6	CALL	0	1	141.78	FALSE	0	0
2026-09-18	11	0	CALL	0	1	140.87	FALSE	0	0
2026-09-18	12	3.6	CALL	0	1	143.94	FALSE	0	0
2026-09-18	13	0	CALL	0	0	143.41	FALSE	0	0
2026-09-18	14	0	CALL	0	0	144.64	FALSE	0	0
2026-09-18	15	2.5	CALL	0	20	142.47	FALSE	0	0
2026-09-18	16	2.07	CALL	0	23	145.05	FALSE	0	0
2026-09-18	17	1.8	CALL	0	1	144.36	FALSE	0	0
2026-09-18	18	1.8	CALL	0	1	145.98	FALSE	0	0
2026-09-18	20	0	CALL	0	0	148.11	FALSE	0	0
2026-09-18	2	0	PUT	0	0	316.13	FALSE	0	0
2026-09-18	3	0	PUT	0	0	180.54	FALSE	0	0
2026-09-18	4	0	PUT	0	0	142.08	FALSE	0	0
2026-09-18	5	0	PUT	0	0	141.56	FALSE	0	0
2026-09-18	6	0	PUT	0	0	148.96	FALSE	0	0
2026-09-18	7	1.82	PUT	0	22	102.44	TRUE	0	0
2026-09-18	8	0	PUT	0	0	79.46	TRUE	0	0
2026-09-18	9	2.45	PUT	0	1	74.14	TRUE	0	0
2026-09-18	10	3.5	PUT	0	7	75.9	TRUE	0	0
2026-09-18	11	4.5	PUT	0	5	67.88	TRUE	0	0
2026-09-18	12	0	PUT	0	0	71.89	TRUE	0	0
2026-09-18	13	0	PUT	0	0	63.29	TRUE	0	0
2026-09-18	14	0	PUT	0	0	0	TRUE	0	0
2026-09-18	15	6.8	PUT	0	1	0	TRUE	0	0
2026-09-18	16	0	PUT	0	0	0	TRUE	0	0
2026-09-18	17	0	PUT	0	0	0	TRUE	0	0
2026-09-18	18	0	PUT	0	0	0	TRUE	0	0
2026-09-18	20	0	PUT	0	0	0	TRUE	0	0
2027-01-15	1	0	CALL	0	0	0	TRUE	0	0
2027-01-15	2	12.6	CALL	0	1	97.99	TRUE	0	0
2027-01-15	3	11.26	CALL	0	1	108.85	TRUE	0	0
2027-01-15	4	9.7	CALL	0	5	114.51	TRUE	0	0
2027-01-15	5	7.12	CALL	0	141	123.96	TRUE	0	0
2027-01-15	7	5.24	CALL	0	5	125.05	FALSE	0	0
2027-01-15	10	2.5	CALL	0	57	102.44	FALSE	0	0
2027-01-15	12	4	CALL	0	21	147.9	FALSE	0	0
2027-01-15	15	3.31	CALL	0	3954	134.63	FALSE	0	0
2027-01-15	17	2.75	CALL	0	17	158.71	FALSE	0	0
2027-01-15	20	2.5	CALL	0	1	163.53	FALSE	0	0
2027-01-15	22	0	CALL	0	0	187.26	FALSE	0	0
2027-01-15	25	1.47	CALL	0	41	313.16	FALSE	0	0
2027-01-15	27	1.71	CALL	0	121	200.68	FALSE	0	0
2027-01-15	1	0	PUT	0	0	0	FALSE	0	0
2027-01-15	2	0	PUT	0	0	0	FALSE	0	0
2027-01-15	3	0.4	PUT	0	20	0	FALSE	0	0
2027-01-15	4	0	PUT	0	2	143.47	FALSE	0	0
2027-01-15	5	1.3	PUT	0	123	159.13	FALSE	0	0
2027-01-15	7	1.86	PUT	0	1	141.92	TRUE	0	0
2027-01-15	10	0	PUT	0	0	141.14	TRUE	0	0
2027-01-15	12	0	PUT	0	0	137.35	TRUE	0	0
2027-01-15	15	0	PUT	0	0	134.3	TRUE	0	0
2027-01-15	17	0	PUT	0	0	137.4	TRUE	0	0
2027-01-15	20	10.2	PUT	0	0	129.98	TRUE	0	0
2027-01-15	22	0	PUT	0	0	129.79	TRUE	0	0
2027-01-15	25	0	PUT	0	0	136.17	TRUE	0	0
2027-01-15	27	0	PUT	0	0	126.02	TRUE	0	0

Latest FULC Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	48	$4.18
Jun 13, 2022 7:59 PM EST	10	$4.18
Jun 13, 2022 7:59 PM EST	100	$4.185
Jun 13, 2022 7:59 PM EST	100	$4.18
Jun 13, 2022 7:59 PM EST	112	$4.18

Fulcrum Therapeutics, Inc (FULC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2019-05-29	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1680581/000000000019009042/0000000000-19-009042-index.htm
2019-06-19	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1680581/000000000019009993/0000000000-19-009993-index.htm
2020-06-24	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1680581/000000000020005645/0000000000-20-005645-index.htm
2020-08-12	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1680581/000000000020007385/0000000000-20-007385-index.htm
2020-02-07	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000031506620000982/0000315066-20-000982-index.htm
2020-09-18	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000089914020000435/0000899140-20-000435-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924319019806/0000899243-19-019806-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924319019807/0000899243-19-019807-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924319019809/0000899243-19-019809-index.htm
2019-07-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924319020026/0000899243-19-020026-index.htm
2019-07-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924319020029/0000899243-19-020029-index.htm
2019-07-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924319020073/0000899243-19-020073-index.htm
2020-01-06	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320000461/0000899243-20-000461-index.htm
2020-01-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320000462/0000899243-20-000462-index.htm
2020-01-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320002034/0000899243-20-002034-index.htm
2020-01-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320002035/0000899243-20-002035-index.htm
2020-01-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-01-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320002040/0000899243-20-002040-index.htm
2020-01-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320002041/0000899243-20-002041-index.htm
2020-02-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320003272/0000899243-20-003272-index.htm
2020-02-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-02-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005300/0000899243-20-005300-index.htm
2020-02-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-03-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-05-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320012820/0000899243-20-012820-index.htm
2020-05-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014415/0000899243-20-014415-index.htm
2020-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015784/0000899243-20-015784-index.htm
2020-06-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015959/0000899243-20-015959-index.htm
2020-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320016496/0000899243-20-016496-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320016497/0000899243-20-016497-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320016498/0000899243-20-016498-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320016499/0000899243-20-016499-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320016500/0000899243-20-016500-index.htm
2020-06-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320017758/0000899243-20-017758-index.htm
2020-06-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-07-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2020-07-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018815/0000899243-20-018815-index.htm
2020-07-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-09-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000089924320024982/0000899243-20-024982-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000090342319000302/0000903423-19-000302-index.htm
2019-05-01	DRS	Draft Registration Statement	https://www.sec.gov/Archives/edgar/data/1680581/000091205719000198/0000912057-19-000198-index.htm
2019-06-06	DRS/A	Draft Registration Statement	https://www.sec.gov/Archives/edgar/data/1680581/000091205719000241/0000912057-19-000241-index.htm
2020-02-20	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000091957420001785/0000919574-20-001785-index.htm
2019-06-21	S-1	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1680581/000104746919003793/0001047469-19-003793-index.htm
2019-07-08	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1680581/000104746919004014/0001047469-19-004014-index.htm
2019-07-12	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1680581/000104746919004158/0001047469-19-004158-index.htm
2019-07-18	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1680581/000104746919004265/0001047469-19-004265-index.htm
2019-07-22	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000104746919004324/0001047469-19-004324-index.htm
2019-06-21	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1680581/000110465919037024/0001104659-19-037024-index.htm
2019-06-26	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1680581/000110465919037583/0001104659-19-037583-index.htm
2019-07-12	8-A12B	Registration of securities [Section 12(b)]	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040208/0001104659-19-040208-index.htm
2019-07-15	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040331/0001104659-19-040331-index.htm
2019-07-15	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040333/0001104659-19-040333-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040809/0001104659-19-040809-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040810/0001104659-19-040810-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040811/0001104659-19-040811-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040812/0001104659-19-040812-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040813/0001104659-19-040813-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040814/0001104659-19-040814-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040815/0001104659-19-040815-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040816/0001104659-19-040816-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040817/0001104659-19-040817-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040818/0001104659-19-040818-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040819/0001104659-19-040819-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040820/0001104659-19-040820-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040821/0001104659-19-040821-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040965/0001104659-19-040965-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040966/0001104659-19-040966-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040967/0001104659-19-040967-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040968/0001104659-19-040968-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040969/0001104659-19-040969-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040970/0001104659-19-040970-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040971/0001104659-19-040971-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040972/0001104659-19-040972-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919040973/0001104659-19-040973-index.htm
2019-07-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041303/0001104659-19-041303-index.htm
2019-07-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041304/0001104659-19-041304-index.htm
2019-07-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041307/0001104659-19-041307-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000110465920020454/0001104659-20-020454-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1680581/000114036119013355/0001140361-19-013355-index.htm
2019-07-29	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000114420419036332/0001144204-19-036332-index.htm
2019-07-29	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000119312519204925/0001193125-19-204925-index.htm
2019-08-26	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000119312519228512/0001193125-19-228512-index.htm
2019-08-26	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1680581/000119312519228520/0001193125-19-228520-index.htm
2019-10-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000119312519262065/0001193125-19-262065-index.htm
2019-12-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000119312519325397/0001193125-19-325397-index.htm
2020-01-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000119312520001768/0001193125-20-001768-index.htm
2020-02-05	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000119312520025424/0001193125-20-025424-index.htm
2020-02-05	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000119312520025429/0001193125-20-025429-index.htm
2020-03-05	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1680581/000119312520063092/0001193125-20-063092-index.htm
2020-04-29	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1680581/000119312520124813/0001193125-20-124813-index.htm
2020-04-29	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1680581/000119312520124825/0001193125-20-124825-index.htm
2020-06-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000119312520165696/0001193125-20-165696-index.htm
2020-06-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000119312520166654/0001193125-20-166654-index.htm
2020-06-22	S-1	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1680581/000119312520175588/0001193125-20-175588-index.htm
2020-06-24	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1680581/000119312520177487/0001193125-20-177487-index.htm
2020-06-26	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000119312520181057/0001193125-20-181057-index.htm
2020-07-23	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000119312520197820/0001193125-20-197820-index.htm
2020-08-11	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1680581/000119312520215668/0001193125-20-215668-index.htm
2020-08-11	POS AM	Post-Effective amendments for registration statement	https://www.sec.gov/Archives/edgar/data/1680581/000119312520215674/0001193125-20-215674-index.htm
2020-08-13	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1680581/000119312520219029/0001193125-20-219029-index.htm
2019-07-15	CERT	Certification	https://www.sec.gov/Archives/edgar/data/1680581/000135445719000348/0001354457-19-000348-index.htm
2020-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1680581/000138713120001784/0001387131-20-001784-index.htm
2019-06-05	DRSLTR	Correspondence Related to Draft Registration Statement	https://www.sec.gov/Archives/edgar/data/1680581/000141057819000287/0001410578-19-000287-index.htm
2019-08-26	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1680581/000156459019032952/0001564590-19-032952-index.htm
2019-11-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000156459019043359/0001564590-19-043359-index.htm
2019-11-14	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1680581/000156459019043378/0001564590-19-043378-index.htm
2020-03-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000156459020008800/0001564590-20-008800-index.htm
2020-03-05	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1680581/000156459020008951/0001564590-20-008951-index.htm
2020-04-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000156459020014860/0001564590-20-014860-index.htm
2020-05-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000156459020024846/0001564590-20-024846-index.htm
2020-05-13	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1680581/000156459020024866/0001564590-20-024866-index.htm
2020-08-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1680581/000156459020039117/0001564590-20-039117-index.htm
2020-08-11	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1680581/000156459020039121/0001564590-20-039121-index.htm
2016-07-25	D	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1680581/000168058116000001/0001680581-16-000001-index.htm
2017-05-10	D	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1680581/000168058117000001/0001680581-17-000001-index.htm
2017-07-25	D/A	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1680581/000168058117000002/0001680581-17-000002-index.htm
2018-09-05	D	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1680581/000168058118000002/0001680581-18-000002-index.htm
2020-06-11	D	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1680581/000168058120000001/0001680581-20-000001-index.htm
2019-07-17	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1680581/999999999519001628/9999999995-19-001628-index.htm
2020-06-26	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1680581/999999999520001702/9999999995-20-001702-index.htm
2020-08-12	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1680581/999999999520002111/9999999995-20-002111-index.htm
2020-08-17	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1680581/999999999520002175/9999999995-20-002175-index.htm
2019-05-13	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1680581/999999999719004388/9999999997-19-004388-index.htm
2019-06-20	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1680581/999999999719005683/9999999997-19-005683-index.htm

Fulcrum Therapeutics, Inc (FULC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fulcrum Therapeutics, Inc (FULC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3552%
Institutional Ownership: 7611%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2020-02-19	Owen B. Wallace	Chief Scientific Officer	Sell	6,088.00	20.00	121,760.00	127,088.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-05-26	Owen B. Wallace	Chief Scientific Officer	Sell	412.00	20.00	8,240.00	127,088.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-27	Owen B. Wallace	Chief Scientific Officer	Sell	448.00	20.00	8,960.00	127,088.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-05-28	Owen B. Wallace	Chief Scientific Officer	Sell	2,232.00	20.00	44,640.00	127,088.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-06-30	Owen B. Wallace	Chief Scientific Officer	Sell	141.00	20.00	2,820.00	127,088.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-07-08	Owen B. Wallace	Chief Scientific Officer	Sell	2,951.00	20.00	59,020.00	127,088.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-06-30	Owen B. Wallace	Chief Scientific Officer	Buy	141.00	7.84	1,105.44	127,229.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-05-26	Owen B. Wallace	Chief Scientific Officer	Buy	412.00	7.84	3,230.08	127,500.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-27	Owen B. Wallace	Chief Scientific Officer	Buy	448.00	7.84	3,512.32	127,536.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-05-28	Owen B. Wallace	Chief Scientific Officer	Buy	2,232.00	7.84	17,498.88	129,320.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-07-08	Owen B. Wallace	Chief Scientific Officer	Buy	2,951.00	7.84	23,135.84	130,039.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-02-19	Owen B. Wallace	Chief Scientific Officer	Buy	6,088.00	7.84	47,729.92	133,176.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-09-14	Owen B. Wallace	Chief Scientific Officer	Buy	6,350.00	7.84	49,784.00	133,438.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320024982/0000899243-20-024982-index.htm
2020-05-11	Peter G. Thomson	VP Finance & Accounting	Sell	7,500.00	16.00	120,000.00	21,071.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320012820/0000899243-20-012820-index.htm
2019-07-22	Third Rock Ventures IV, L.P.	10% Share Holder	Buy	81,250.00	16.00	1,300,000.00	2,343,154.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924319020029/0000899243-19-020029-index.htm
2020-02-24	Peter G. Thomson	VP Finance & Accounting	Sell	250.00	18.61	4,653.00	28,571.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-02-24	Peter G. Thomson	VP Finance & Accounting	Sell	2,102.00	17.43	36,643.33	28,821.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-02-24	Peter G. Thomson	VP Finance & Accounting	Sell	2,648.00	16.18	42,856.56	30,923.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-01-23	Peter G. Thomson	VP Finance & Accounting	Sell	262.00	18.05	4,730.12	33,571.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-01-23	Peter G. Thomson	VP Finance & Accounting	Sell	4,738.00	17.17	81,371.83	33,833.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-07-08	Robert J Gould	Officer	Sell	2,500.00	20.00	50,000.00	534,845.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018815/0000899243-20-018815-index.htm
2020-06-25	Robert J Gould	Officer	Sell	2,500.00	20.80	51,992.00	537,345.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320017758/0000899243-20-017758-index.htm
2020-06-09	Robert J Gould	Officer	Sell	156.00	20.00	3,120.00	539,845.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015959/0000899243-20-015959-index.htm
2020-06-05	Robert J Gould	Officer	Sell	3,433.00	20.17	69,251.16	540,001.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015784/0000899243-20-015784-index.htm
2020-06-04	Robert J Gould	Officer	Sell	1,300.00	20.04	26,057.98	543,434.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-03	Robert J Gould	Officer	Sell	1,500.00	20.13	30,192.45	544,734.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-02	Robert J Gould	Officer	Sell	2,797.00	20.00	55,940.00	546,234.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-06-01	Robert J Gould	Officer	Sell	5.00	20.00	100.00	549,031.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-05-29	Robert J Gould	Officer	Sell	1,390.00	20.08	27,910.78	549,036.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-05-28	Robert J Gould	Officer	Sell	1,919.00	20.01	38,391.13	550,426.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-05-26	Robert J Gould	Officer	Sell	2,500.00	20.00	50,000.00	552,345.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014415/0000899243-20-014415-index.htm
2020-02-19	Robert J Gould	Officer	Sell	2,500.00	20.00	50,000.00	554,845.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320005300/0000899243-20-005300-index.htm
2019-07-22	Sanofi	10% Share Holder	Buy	93,750.00	16.00	1,500,000.00	558,035.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924319020073/0000899243-19-020073-index.htm
2019-07-22	6 Dimensions Capital, L.P.	10% Share Holder	Buy	118,750.00	16.00	1,900,000.00	559,821.00	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041307/0001104659-19-041307-index.htm
2019-07-22	Casdin Capital, LLC	10% Share Holder	Buy	125,000.00	16.00	2,000,000.00	589,285.00	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-22	MARK J LEVIN	Director	Buy	81,250.00	16.00	1,300,000.00	5,962,202.00	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041304/0001104659-19-041304-index.htm
2019-07-22	Third Rock Ventures III, L.P.	10% Share Holder	Buy	81,250.00	16.00	1,300,000.00	5,962,202.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924319020026/0000899243-19-020026-index.htm
2019-07-22	Casdin Capital, LLC	10% Share Holder	Buy	10,000.00	14.50	144,996.00	599,285.00	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-22	Casdin Capital, LLC	10% Share Holder	Buy	5,000.00	14.50	72,499.00	604,285.00	https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2020-07-01	Diego Cadavid	SVP Clinical Development	Sell	1,071.00	18.30	19,599.30	65,714.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2020-03-02	Diego Cadavid	SVP Clinical Development	Sell	315.00	18.13	5,709.53	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-05-12	Diego Cadavid	SVP Clinical Development	Sell	1,860.00	18.00	33,480.00	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-05-28	Diego Cadavid	SVP Clinical Development	Sell	600.00	20.00	12,000.00	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-05-29	Diego Cadavid	SVP Clinical Development	Sell	200.00	20.04	4,007.00	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-02	Diego Cadavid	SVP Clinical Development	Sell	45.00	20.00	900.00	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-03	Diego Cadavid	SVP Clinical Development	Sell	338.00	20.18	6,819.59	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-04	Diego Cadavid	SVP Clinical Development	Sell	226.00	20.05	4,531.25	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-05	Diego Cadavid	SVP Clinical Development	Sell	451.00	20.18	9,100.77	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-10	Diego Cadavid	SVP Clinical Development	Sell	401.00	22.00	8,822.00	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-25	Diego Cadavid	SVP Clinical Development	Sell	1,459.00	22.00	32,098.00	66,785.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-06-02	Diego Cadavid	SVP Clinical Development	Buy	45.00	4.83	217.35	66,830.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-05-29	Diego Cadavid	SVP Clinical Development	Buy	200.00	4.83	966.00	66,985.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-04	Diego Cadavid	SVP Clinical Development	Buy	226.00	4.83	1,091.58	67,011.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-03-02	Diego Cadavid	SVP Clinical Development	Sell	1,828.00	17.26	31,545.25	67,100.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-06-03	Diego Cadavid	SVP Clinical Development	Buy	338.00	4.83	1,632.54	67,123.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-10	Diego Cadavid	SVP Clinical Development	Buy	401.00	4.83	1,936.83	67,186.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-05	Diego Cadavid	SVP Clinical Development	Buy	451.00	4.83	2,178.33	67,236.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-05-28	Diego Cadavid	SVP Clinical Development	Buy	600.00	4.83	2,898.00	67,385.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-25	Diego Cadavid	SVP Clinical Development	Buy	1,459.00	4.83	7,046.97	68,244.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-05-12	Diego Cadavid	SVP Clinical Development	Buy	1,860.00	4.83	8,983.80	68,645.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-02-03	Diego Cadavid	SVP Clinical Development	Sell	2,143.00	17.33	37,141.83	68,928.00	https://www.sec.gov/Archives/edgar/data/1680581/000089924320003272/0000899243-20-003272-index.htm

Fulcrum Therapeutics, Inc

(NASDAQ:FULC)